Over the past 12 months, 2 insiders at Cidara Therapeutics, Inc. filed 2 open-market SEC Form 4 transactions on CDTX: 0 purchases worth $0 and 2 sales worth $2.2M. Insiders have been net sellers over this period. The most recent filing was on Dec 10, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 10, 25 | Shane WardCOO & CLO | SELL | 10.0K | $220.08 | $2.2M |
| Sep 11, 25 | Nicole Negar DavarpanahChief Medical Officer | SELL | 474 | $62.86 | $30K |
| Jun 26, 25 | Peter KolchinskyDirector,TenPercentOwner | BUY | 2.27M | $44.00 | $100.0M |
| Jun 3, 25 | Chrysa MineoDirector | BUY | 1.1K | $23.44 | $25K |
| Jun 2, 25 | Chrysa MineoDirector | BUY | 2.3K | $21.71 | $49K |
| Mar 11, 25 | Leslie TariCHIEF SCIENTIFIC OFFICER | SELL | 1.8K | $21.96 | $39K |
| Mar 11, 25 | Shane WardCOO & CLO | SELL | 1.7K | $21.96 | $37K |
| Sep 11, 24 | Taylor SandisonChief Medical Officer | SELL | 924 | $11.64 | $11K |
| Sep 11, 24 | Leslie TariCHIEF SCIENTIFIC OFFICER | SELL | 909 | $11.64 | $11K |
| Jun 7, 24 | Jeffrey SteinPresident & CEO | BUY | 8.0K | $13.21 | $106K |
| Mar 11, 24 | Taylor SandisonChief Medical Officer | SELL | 20.7K | $0.67 | $14K |
| Mar 11, 24 | Preetam ShahCFO & CBO | SELL | 18.9K | $0.67 | $13K |
| Mar 11, 24 | Leslie TariCHIEF SCIENTIFIC OFFICER | SELL | 21.0K | $0.67 | $14K |
| Mar 11, 24 | Shane WardCOO & CLO | SELL | 20.5K | $0.67 | $14K |
| Sep 11, 23 | Taylor SandisonChief Medical Officer | SELL | 18.8K | $0.95 | $18K |
| Sep 11, 23 | Leslie TariCHIEF SCIENTIFIC OFFICER | SELL | 18.5K | $0.95 | $18K |
| Aug 14, 23 | Leslie TariCHIEF SCIENTIFIC OFFICER | BUY | 10.0K | $0.97 | $10K |
| Aug 8, 23 | Jeffrey SteinPresident & CEO | BUY | 50.0K | $0.96 | $48K |
| Mar 27, 23 | Jeffrey SteinPresident & CEO | BUY | 50.0K | $1.04 | $52K |
| Mar 13, 23 | Taylor SandisonChief Medical Officer | SELL | 7.2K | $1.53 | $11K |
| Mar 13, 23 | Preetam ShahCFO & CBO | SELL | 6.6K | $1.53 | $10K |
| Mar 13, 23 | Leslie TariCHIEF SCIENTIFIC OFFICER | SELL | 7.6K | $1.53 | $12K |
| Mar 13, 23 | Shane WardCOO & CLO | SELL | 4.3K | $1.53 | $7K |
| Jan 12, 23 | Leslie TariCHIEF SCIENTIFIC OFFICER | SELL | 11.8K | $1.20 | $14K |
| Sep 19, 22 | Preetam ShahCFO & CBO | SELL | 15.6K | $0.77 | $12K |
| Sep 12, 22 | Paul DaruwalaChief Operating Officer | SELL | 16.2K | $0.68 | $11K |
| Sep 12, 22 | Taylor SandisonChief Medical Officer | SELL | 18.5K | $0.68 | $13K |
| Sep 12, 22 | Leslie TariCHIEF SCIENTIFIC OFFICER | SELL | 18.2K | $0.68 | $12K |
| Mar 21, 22 | Brady JohnsonVice President, Finance | SELL | 654 | $0.81 | $530 |
| Mar 11, 22 | Brady JohnsonVice President, Finance | SELL | 945 | $0.71 | $671 |
| Jan 5, 22 | Paul DaruwalaChief Operating Officer | SELL | 5.1K | $1.25 | $6K |
| Jan 5, 22 | Brady JohnsonVice President, Finance | SELL | 416 | $1.25 | $520 |
| Jan 5, 22 | Leslie TariChief Scientific Officer | SELL | 1.3K | $1.25 | $2K |
| Nov 12, 21 | Preetam ShahCFO & CBO | BUY | 20.0K | $1.54 | $31K |
| Nov 12, 21 | Jeffrey SteinPresident & CEO | BUY | 50.0K | $1.59 | $80K |
| Sep 13, 21 | Timothy R FransonDirector | BUY | 7.0K | $2.12 | $15K |
| Aug 19, 21 | Jeffrey SteinPresident & CEO | BUY | 10.0K | $1.79 | $18K |
| Aug 18, 21 | Jeffrey SteinPresident & CEO | BUY | 40.0K | $1.72 | $69K |
Over the past 12 months, insiders at Cidara Therapeutics, Inc. filed 0 open-market purchases worth $0 and 2 sales worth $2.2M on CDTX, which makes them net sellers over the period. The most recent Form 4 was filed on Dec 10, 25.
The largest recent open-market CDTX insider purchase in our data was $100.0M by Peter Kolchinsky, Director,TenPercentOwner, filed on Jun 26, 25.
2 different insiders at Cidara Therapeutics, Inc. filed open-market SEC Form 4 transactions on CDTX over the last 12 months.
InsiderTape plots every CDTX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Cidara Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →